Zhejiang Xianju Pharmaceutical Co.,Ltd.

002332

CNE100000K64

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
11.41 ^CNY	-0.87%		-5.31%	-10.65%

05-30	Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024	CI
05-22	Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023	CI

Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections

December 26, 2022 at 07:48 pm

Zhejiang Xianju Pharmaceutical Co.,Ltd. at its EGM held on December 23, 2022 approved election of Hao Yunhong and Liu Bin as independent directors and Wu Tianfei and Wang Yong as non-employee supervisors.

Latest news about Zhejiang Xianju Pharmaceutical Co.,Ltd.

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024	05-30	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023	05-21	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023	04-24	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm	12-27	MT
Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 80 million in funding from Zhejiang Xianju Pharmaceutical Co.,Ltd., Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.), Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.), Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.)	12-25	CI
Zhejiang Xianju Pharmaceutical's Flumazenil Injection Chosen for China's Centralized Bid	11-08	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023	29/05/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022	24/05/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2022	26/04/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Zhejiang Xianju Pharma’s Abortion Tablet Passes Consistency Evaluation	10/03/23	MT
Zhejiang Xianju Pharma Logs 20.4% Jump in 2022 Profit	24/02/23	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/02/23	CI
Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 8 million.	28/12/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections	26/12/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component A Share Index	09/12/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component Index	09/12/22	CI
Zhejiang Xianju Pharmaceutical Receives Regulatory Approval for Injection	02/11/22	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 8, 2022	31/05/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves 2021 Profit Distribution Plan	13/05/22	CI

Chart Zhejiang Xianju Pharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Xianju Pharmaceutical Co.,Ltd.

More charts

Company Profile

ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, manufacture and distribution of steroid active pharmaceutical ingredients (APIs) and preparations. The Company's products are mainly categorized into cortex hormone drugs, gynecology and family planning drugs, as well as anesthesia drugs and muscle relaxants. The Company is also involved in the provision of respiratory drugs, immunomodulators, dermatology drugs, anaesthetic drugs and others. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Zhejiang Xianju Pharmaceutical Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

11.41 CNY

Average target price

15.21 CNY

Spread / Average Target

+33.30%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD.	-10.65%	1.55B
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B

Other Pharmaceuticals